Evidence map›Paper›PMID 36009432›Full record

ArticleBiomedicines2022

miRNome and Proteome Profiling of Small Extracellular Vesicles Secreted by Human Glioblastoma Cell Lines and Primary Cancer Stem Cells.

Ingrid Cifola, Federica Fratini, Beatrice Cardinali, Valentina Palmieri, Giuliana Gatti, Tommaso Selmi, Sara Donzelli, Andrea Sacconi, Valeriana Cesarini, Hany E Marei and 5 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Improvement of small extracellular vesicle isolation from mouse model blood.Extracellular vesicles and circulating nucleic acids · 2025
    Article
  7. Understanding AβMetabolic brain disease · 2024
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 2 countries.

Ingrid CifolaInstitute for Biomedical Technologies (ITB), CNR, 20054 Segrate, Italy.ORCID 0000-0003-2819-1171
Federica FratiniProteomics Core Facility, Istituto Superiore di Sanità (ISS), 00161 Rome, Italy.ORCID 0000-0003-0807-930X
Beatrice CardinaliInstitute of Biochemistry and Cell Biology (IBBC), CNR, 00015 Monterotondo, Italy.ORCID 0000-0002-3333-3384
Valentina PalmieriFondazione Policlinico Universitario A. Gemelli IRCSS, 00168 Rome, Italy.ORCID 0000-0002-6358-9647
Giuliana GattiDepartment of Biotechnology and Translational Medicine, University of Milan, 20129 Milan, Italy.ORCID 0000-0001-8844-4543
Tommaso SelmiInstitute for Biomedical Technologies (ITB), CNR, 20054 Segrate, Italy.ORCID 0000-0001-6262-7704
Sara DonzelliTranslational Oncology Research Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
Andrea SacconiClinical Trial Center, Biostatistics and Bioinformatics Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.ORCID 0000-0002-8276-0438
Valeriana CesariniInstitute of Translational Pharmacology (IFT), CNR, 00133 Rome, Italy.
Hany E MareiDepartment of Cytology and Histology, Faculty of Veterinary Medicine, Mansoura University, Mansoura 35116, Egypt.
Massimilano PapiFondazione Policlinico Universitario A. Gemelli IRCSS, 00168 Rome, Italy.ORCID 0000-0002-0029-1309
Giovanni BlandinoTranslational Oncology Research Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
Carlo CenciarelliInstitute of Translational Pharmacology (IFT), CNR, 00133 Rome, Italy.
Germana FalconeInstitute of Biochemistry and Cell Biology (IBBC), CNR, 00015 Monterotondo, Italy.ORCID 0000-0002-3508-7623
Igea D'AgnanoInstitute for Biomedical Technologies (ITB), CNR, 20054 Segrate, Italy.ORCID 0000-0002-2646-9224
Institute of Biomedical Technologies · ITInstitute of Cell Biology and Neurobiology · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITIstituto di Farmacologia Traslazionale · ITUniversità Cattolica del Sacro Cuore · ITIstituto Superiore di Sanità · ITMansoura University · EGUniversity of Milan · IT

Funding

Italian Ministry for Education, University and Research Under the framework of the Flagship Project Interomics
6 · The paper itself

Abstract

Glioblastoma (GBM) is the most common and aggressive brain tumor in adults. Despite available therapeutic interventions, it is very difficult to treat, and a cure is not yet available. The intra-tumoral GBM heterogeneity is a crucial factor contributing to poor clinical outcomes. GBM derives from a small heterogeneous population of cancer stem cells (CSCs). In cancer tissue, CSCs are concentrated within the so-called niches, where they progress from a slowly proliferating phase. CSCs, as most tumor cells, release extracellular vesicles (EVs) into the surrounding microenvironment. To explore the role of EVs in CSCs and GBM tumor cells, we investigated the miRNA and protein content of the small EVs (sEVs) secreted by two GBM-established cell lines and by GBM primary CSCs using omics analysis. Our data indicate that GBM-sEVs are selectively enriched for miRNAs that are known to display tumor suppressor activity, while their protein cargo is enriched for oncoproteins and tumor-associated proteins. Conversely, among the most up-regulated miRNAs in CSC-sEVs, we also found pro-tumor miRNAs and proteins related to stemness, cell proliferation, and apoptosis. Collectively, our findings support the hypothesis that sEVs selectively incorporate different miRNAs and proteins belonging both to fundamental processes (e.g., cell proliferation, cell death, stemness) as well as to more specialized ones (e.g., EMT, membrane docking, cell junction organization, ncRNA processing).

Indexed as

cancer stem cellsextracellular vesiclesglioblastomamiRNAsproteome

Identifiers

PMID36009432
PMCPMC9405730
OpenAlexW4289985756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.